Sera Prognostics, Atreca spike after Baker Bros investments

seekingalpha

2024-01-12

Shares of Sera Prognostics (NASDAQ:SERA) and Atreca (NASDAQ:BCEL) traded higher on Thursday after hedge fund manager Baker Bros. Advisors disclosed investments in the companies.
According to 13G filings on Wednesday, the New York-based financial services firm has disclosed a passive stake of ~18% in Sera Prognostics (SERA), a Salt Lake City, Utah-based diagnostics firm focused on women's health.
Another SEC filing from Atreca (BCEL) indicated that Baker Bros.'s investment in the immunotherapy developer rose to ~20%, or ~7.7M shares, up from ~3.5M. The San Carlos, California-based nano-cap biotech develops antibody-based drugs for cancer.
According to other 13G reports filed by Baker Bros. on Wednesday, it has increased its stakes in Kymera Therapeutics (KYMR) and Replimune (REPL) to ~11% and ~16%, respectively.

More on Atreca, Sera Prognostics, etc.

Sera Prognostics: The Pregnancy Company On A Hot Streak
Sera Prognostics, Inc (SERA) Q3 2023 Earnings Call Transcript
Biggest stock movers today: Google, AMD, GameStop, C3.AI, Chewy and more
Sera Prognostics shares rocket 160% on PreTRM study update
Seeking Alpha’s Quant Rating on Atreca

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2402018724"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2402018724\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2402018724?lang=zh_CN&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1294384963/image_1294384963.jpg","is_english":true,"pubTime":"2024-01-12 02:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2402018724","market":"us","top_or_hot":-1,"title":"Sera Prognostics, Atreca spike after Baker Bros investments","media":"seekingalpha","content":"<html><body><ul> <li>Shares of Sera Prognostics (<span>NASDAQ:SERA</span>) and <a href=\"https://laohu8.com/S/BCEL\">Atreca</a> (<span>NASDAQ:BCEL</span>) traded higher on Thursday after hedge fund manager Baker Bros. Advisors disclosed investments in the companies.</li> <li>According to 13G filings on Wednesday, the New York-based financial services firm has disclosed a passive stake of ~18%<span> in Sera Prognostics (</span>SERA<span>), a Salt Lake City, Utah-based diagnostics firm focused on women's health.</span> </li> <li>Another SEC filing from Atreca (BCEL) indicated that Baker Bros.'s investment in the immunotherapy developer rose to ~20%, or ~7.7M shares, up from ~3.5M. The San Carlos, California-based nano-cap biotech develops antibody-based drugs for cancer.</li> <li>According to other 13G reports filed by Baker Bros. on Wednesday, it has increased its stakes in Kymera Therapeutics (KYMR) and Replimune (REPL) to ~11% and ~16%, respectively.</li> </ul> <div> <h2>More on Atreca, Sera Prognostics, etc.</h2> <ul> <li>Sera Prognostics: The Pregnancy Company On A Hot Streak</li> <li>Sera Prognostics, Inc (SERA) Q3 2023 Earnings Call Transcript</li> <li>Biggest stock movers today: Google, AMD, GameStop, C3.AI, Chewy and more</li> <li>Sera Prognostics shares rocket 160% on PreTRM study update</li> <li>Seeking Alpha’s Quant Rating on Atreca</li> </ul> </div></body></html>","source":"seekingalpha_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sera Prognostics, Atreca spike after Baker Bros investments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSera Prognostics, Atreca spike after Baker Bros investments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-12 02:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4054463-sera-prognostics-atreca-spike-baker-bros-stakes><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Sera Prognostics (NASDAQ:SERA) and Atreca (NASDAQ:BCEL) traded higher on Thursday after hedge fund manager Baker Bros. Advisors disclosed investments in the companies. According to 13G ...</p>\n\n<a href=\"https://seekingalpha.com/news/4054463-sera-prognostics-atreca-spike-baker-bros-stakes\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://seekingalpha.com/news/4054463-sera-prognostics-atreca-spike-baker-bros-stakes","article_id":"2402018724","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1294384963/image_1294384963.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2402018724","pubTimestamp":1704996537,"columns":[],"sourceInfo":{"source_id":"seekingalpha_hot_news","name":"SeekingAlpha"},"weMediaInfo":null,"summary":"Shares of Sera Prognostics  and Atreca  traded higher on Thursday after hedge fund manager Baker Bros. Advisors disclosed investments in the companies. According to 13G filings on Wednesday, the New York-based financial services firm has disclosed a passive stake of ~18% in Sera Prognostics , a Salt Lake City, Utah-based diagnostics firm focused on women's health.  Another SEC filing from Atreca  indicated that Baker Bros.'s investment in the immunotherapy developer rose to ~20%, or ~7.7M shares, up from ~3.5M. The San Carlos, California-based nano-cap biotech develops antibody-based drugs for cancer. According to other 13G reports filed by Baker Bros. on Wednesday, it has increased its stakes in Kymera Therapeutics  and Replimune  to ~11% and ~16%, respectively.   More on Atreca, Sera Prognostics, etc.  Sera Prognostics: The Pregnancy Company On A Hot Streak Sera Prognostics, Inc  Q3 2023 Earnings Call Transcript Biggest stock movers today: Google, AMD, GameStop, C3.AI, Chewy and more","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Sera预测，贝克兄弟投资后Atreca飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{".IXIC":0.65,"BCEL":1,"MNQmain":0.6,"NQmain":0.6,"KYMR":1,"PSQ":0.6,"QID":0.6,"QLD":0.6,"QQQ":0.6,"REPL":1,"SERA":1,"SQQQ":0.6,"TQQQ":0.6},"content_text":"Shares of Sera Prognostics (NASDAQ:SERA) and Atreca (NASDAQ:BCEL) traded higher on Thursday after hedge fund manager Baker Bros. Advisors disclosed investments in the companies. According to 13G filings on Wednesday, the New York-based financial services firm has disclosed a passive stake of ~18% in Sera Prognostics (SERA), a Salt Lake City, Utah-based diagnostics firm focused on women's health.  Another SEC filing from Atreca (BCEL) indicated that Baker Bros.'s investment in the immunotherapy developer rose to ~20%, or ~7.7M shares, up from ~3.5M. The San Carlos, California-based nano-cap biotech develops antibody-based drugs for cancer. According to other 13G reports filed by Baker Bros. on Wednesday, it has increased its stakes in Kymera Therapeutics (KYMR) and Replimune (REPL) to ~11% and ~16%, respectively.   More on Atreca, Sera Prognostics, etc.  Sera Prognostics: The Pregnancy Company On A Hot Streak Sera Prognostics, Inc (SERA) Q3 2023 Earnings Call Transcript Biggest stock movers today: Google, AMD, GameStop, C3.AI, Chewy and more Sera Prognostics shares rocket 160% on PreTRM study update Seeking Alpha’s Quant Rating on Atreca","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}